AMENDMENT TO RESTATED AND AMENDED LICENSE AGREEMENTLicense Agreement • November 19th, 2007 • MAP Pharmaceuticals, Inc. • Pharmaceutical preparations
This AMENDMENT TO RESTATED AND AMENDED LICENSE AGREEMENT (“Amendment”) is made and entered into effective as of October 8, 2007 (the “Amendment Date”) by and between NEKTAR THERAPEUTICS, UK LIMITED, a limited company organized under the laws of England and Wales having a place of business at 150 Industrial Way, San Carlos, CA 94070, (“NEKTAR UK”) and MAP PHARMACEUTICALS, INC., a Delaware corporation having a place of business at 2400 Bayshore Parkway, Suite 200, Mountain View, CA 94043 (“MAP”). NEKTAR UK and MAP are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
